Differentiation of mechanisms of the antilipolytic actions produced by alpha and beta adrenergic blocking agents.
D000273:Adipose Tissue / Q000201:enzymology* / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008049:Lipase / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D011955:Receptors, Drug; D013565:Sympatholytics; D013806:Theophylline; D000242:Cyclic AMP; D008049:Lipase; D010744:Phosphoric Monoester Hydrolases; D007545:Isoproterenol; D005990:Glycerol; D009638:Norepinephrine; D010646:Phentolamine